Rogco, LP Abb Vie Inc. Transaction History
Rogco, LP
- $245 Billion
- Q1 2024
A detailed history of Rogco, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Rogco, LP holds 8,916 shares of ABBV stock, worth $1.57 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
8,916
Previous 15,298
41.72%
Holding current value
$1.57 Million
Previous $2.37 Billion
31.51%
% of portfolio
0.66%
Previous 1.04%
Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
3,643Shares Held
1.24BCall Options Held
15.5MPut Options Held
11.5M-
Vanguard Group Inc Valley Forge, PA170MShares$30 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY143MShares$25.2 Billion0.61% of portfolio
-
State Street Corp Boston, MA78MShares$13.7 Billion0.64% of portfolio
-
Jpmorgan Chase & CO New York, NY51.3MShares$9.03 Billion0.85% of portfolio
-
Capital International Investors Los Angeles, CA48.1MShares$8.48 Billion1.81% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $312B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...